Screener
Oruka Therapeutics, Inc. ORKA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesNoncurrent.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities, current | 339,309 | 290,109 |
| Prepaid expenses and other current assets | 6,420 | 6,813 |
| Total current assets | 395,249 | 343,857 |
| Marketable securities, long-term | 107,123 | 142,539 |
| Property and equipment, net | 318 | 288 |
| Operating lease right-of-use assets | 1,687 | 1,830 |
| Other non-current assets | 103 | 103 |
| Total assets | $504,480 | $488,617 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Oruka Therapeutics, Inc.'s short-term investments?
- Oruka Therapeutics, Inc. (ORKA) reported short-term investments of $107.12M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s short-term investments changed year-over-year?
- Oruka Therapeutics, Inc.'s short-term investments increased by 347.2% year-over-year, from $23.95M to $107.12M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Oruka Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude